04/03/2025
EuroEyes was awarded in Hong Kong for 58,000 implanted lenses
https://euroeyes.com/euroeyes-again-implanted-the-most-zeiss-trifocal-lenses-worldwide-in-2024/
In 2024, EuroEyes once again implanted the most AT LISA tri intraocular lenses (IOLs) worldwide, further consolidating its leading position in the field of refractive surgery. In the nine consecutive years from 2016 to 2024, EuroEyes has implanted a total of around 58,000 of these high-quality trifocal lenses, making it the only customer with this exclusive status.
The award ceremony took place in Hong Kong, where Dr Jørn S. Jørgensen, Founder, Chairman and CEO of EuroEyes, received the certificate from Magnus Reibenspiess, Head of the Ophthalmology Strategic Business Unit and President of ZEISS Ophthalmology. This honour underlines the many years of successful cooperation between EuroEyes and ZEISS Medical Technology.
Dr Jørgensen expressed his delight at receiving the award again and emphasised the importance it has for the company. He emphasised that the continued recognition reflects not only the trust patients place in EuroEyes, but also the expertise and dedication of the entire team. EuroEyes will continue to strive to offer its patients the most advanced and effective vision correction solutions.
Since its foundation in 1993, EuroEyes has always implanted the latest technology in vision correction to help patients worldwide achieve optimised vision. The company has treated more than 1,000,000 eyes worldwide.
Being repeatedly recognised as the world's largest implanter of ZEISS AT LISA tri IOLs confirms EuroEyes' leading role in refractive surgery and its continuous pursuit of excellence in the service of patients.